Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Way off topic, but why not.l

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jun 15, 2024 5:24pm

61 Views

Post# 36090753

RE:RE:RE:Way off topic, but why not.l

lol...Two more Hilarious examples......two dudes from two universities get paid in taxpayer dollars by the corrupt DOJ ( that has been going after Trump for the last 7 years ) to write an article to go after Trump, .....and then an article from New Yorker magazine, are, in Notable's Trump hatred-glazed eyes, more credible than an official report from the House of Representatives oversite Comittee! ...no wonder this country is going down the tubes!.....this is too much.... once the level of bull gets to deep, I gotta go take a shower.....

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects